ArticleRheumatology international2013

Fibronectin molecular status determination useful to differentiate between rheumatoid arthritis and systemic lupus erythematosus patients.

Magdalena Przybysz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.